"Preclinical data of another oral antiandrogen, an N-substituted aryl hydantoin, RU-58841, suggested topical safety since the cutaneous resorption was low, however, one of the metabolites proved stable and strongly anti-androgenic, and further development was abandoned". http://hairsite2.com/flu.pdf